Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    14734451 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients
Condition: Stage IV Melanoma
Intervention: Drug: Coxsackievirus A21

Study has passed its completion date and status has not been verified in more than two years.